Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001079973-25-001765

Chief Executive Officer acquired 6,211 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Virnich Daniel · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-12 Grant or award : show line 1 in the form +6,211 1,793,520 D
Loading xslF345X05/ownership.xml…